These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10918529)

  • 1. Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats.
    Picard F; Deshaies Y; Lalonde J; Samson P; Labrie C; Bélanger A; Labrie F; Richard D
    Int J Obes Relat Metab Disord; 2000 Jul; 24(7):830-40. PubMed ID: 10918529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
    Lemieux C; Picard F; Labrie F; Richard D; Deshaies Y
    Obes Res; 2003 Mar; 11(3):477-90. PubMed ID: 12634448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
    Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
    J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):79-87. PubMed ID: 15544933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesterolemic action of the selective estrogen receptor modulator acolbifene in intact and ovariectomized rats with diet-induced hypercholesterolemia.
    Lemieux C; Gélinas Y; Lalonde J; Labrie F; Richard D; Deshaies Y
    Metabolism; 2006 May; 55(5):605-13. PubMed ID: 16631436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term treatment with the antiestrogen EM-652.HCl on pituitary estrogen receptor alpha and prolactin mRNA expression in intact, ovariectomized and gonadotropin-releasing hormone-treated female rats.
    Pelletier G; El-Alfy M; Labrie C; Martel C; Labrie F
    Neuroendocrinology; 2001 Dec; 74(6):367-74. PubMed ID: 11752893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
    Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
    Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
    Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
    Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat.
    Deshaies Y; Dagnault A; Lalonde J; Richard D
    Am J Physiol; 1997 Aug; 273(2 Pt 1):E355-62. PubMed ID: 9277389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats.
    Meli R; Pacilio M; Raso GM; Esposito E; Coppola A; Nasti A; Di Carlo C; Nappi C; Di Carlo R
    Endocrinology; 2004 Jul; 145(7):3115-21. PubMed ID: 15059958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementing with Opuntia ficus-indica Mill and Dioscorea nipponica Makino extracts synergistically attenuates menopausal symptoms in estrogen-deficient rats.
    Ko BS; Lee HW; Kim DS; Kang S; Ryuk JA; Park S
    J Ethnopharmacol; 2014 Aug; 155(1):267-76. PubMed ID: 24875644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function.
    Liu ML; Xu X; Rang WQ; Li YJ; Song HP
    Int J Cardiol; 2004 Dec; 97(3):485-93. PubMed ID: 15561337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S; Lévesque C; Geng CS; Yan X; Labrie F
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
    Martel C; Picard S; Richard V; Bélanger A; Labrie C; Labrie F
    J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):45-56. PubMed ID: 11074355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.
    Zeitlin L; Segev E; Fried A; Wientroub S
    J Cell Biochem; 2003 Oct; 90(2):347-60. PubMed ID: 14505351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats.
    Choi JS; Song J
    Nutrition; 2009 Jun; 25(6):676-85. PubMed ID: 19230619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.